-
Welcome to the 2025 Tandem Meetings
ASTCT® and CIBMTR® leaders share their excitement for this year’s premier event for the dissemination of clinical innovations, scientific breakthroughs, and more in the field of HCT and cell and gene therapy.
-
Pediatric plenary to explore stem cell transplant in youngest patients
The pediatric plenary will focus on reducing the toxicity of conditioning regimens and transplant in general without compromising overall survival and event-free survival, said Session Chair Miki Nishitani, MD.
-
Experts to illuminate possible pathways for effective treatment of refractory acute GVHD
Three experts will discuss the underlying mechanisms of refractory acute graft-versus-host disease that may guide the design of future clinical trials. Victor Tkachev, PhD, shares what to expect.
-
Joint session to explore potential of in vivo gene therapy
Ex vivo gene therapy for malignancies and genetic diseases is time consuming, expensive, and physically taxing on patients. John DiPersio, MD, PhD, and Hans-Peter Kiem, MD, PhD, preview this joint session presented by ASTCT and ASGCT on the in vivo alternatives.
-
Session to preview non-malignant biorepository for study coordinators
Larisa Broglie, MD, MS, will give an overview of a study being developed as part of the Blood & Marrow Transplant Clinical Trials Network, which aims to build a biorepository of samples from patients with non-malignant diseases who will undergo hematopoietic cell transplantation and gene therapy for select diseases.
-
Panel to examine landscape of antiviral therapy in pediatric transplant
Caitlin Elgarten, MD, MSCE, previews the positive developments and ongoing challenges that will be addressed in this session on drug development for the treatment and prevention of viral infection in children after transplant.
-
Robert Korngold Award — Editorial Award (Cellular Therapy)
Naokazu Nakamura, MD, this year’s recipient of the Editorial Award for Cellular Therapy, previews his lecture on the clinical impact of CRS on prolonged hematotoxicity after CAR-T therapy.
-
Pediatric Lifetime Achievement Award
Helen, MD, DSc (Hon), the recipient of the Peditaric Lifetime Achievement Award, shares why she first became interested in cellular and gene therapy.